On Monday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.
Here’s why these brokers are bearish on them:
Coca-Cola Amatil Ltd (ASX: CCL)
According to a note out of Goldman Sachs, its analysts have retained their sell rating and $10.70 price target on the beverage giant’s shares following its earnings guidance withdrawal this morning. The broker believes the coronavirus outbreak will have a net negative impact on its ANZ business due to the increasing cancellation of social events. It also believes that sales in Indonesia could suffer if the outbreak persists into the Ramadan period. The Coca-Cola Amatil share price is down at $9.78 this afternoon, which is now lower than Goldman’s price target.
Cochlear Limited (ASX: COH)
Analysts at UBS have retained their sell rating and cut the price target on this hearing solutions company’s shares to $165.00 after it withdrew its earnings guidance. According to the note, the broker expects Cochlear’s sales to struggle in 2020 due to the coronavirus outbreak and its impact on elective surgeries. And while it expects the company to maintain its dominant market position, it appears concerned that it could take time before unit sales return to historic levels. The Cochlear share price is trading at $171.98 on Tuesday.
Galaxy Resources Limited (ASX: GXY)
A note out of the Macquarie equities desk reveals that its analysts have retained their sell rating and 50 cents price target on this lithium miner’s shares. Although Galaxy shipped far more spodumene concentrate from its Mount Cattlin operation during the first quarter of FY 2020, it notes that management has revised its production guidance lower. And while Macquarie appears confident that lithium prices will improve later this year, it’s still too soon for it to change its rating. The Galaxy share price is up at 85 cents this afternoon.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- The Bubs (ASX:BUB) share price is down 42% in 12 months: Is it a buy? – September 24, 2020 2:14pm
- Top brokers name 3 ASX shares to sell today – September 24, 2020 12:54pm
- New to investing? I would invest $500 into these exciting ASX shares – September 24, 2020 12:05pm